| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 7 securities · may seek to influence control | ||||||
|
ADARx Pharmaceuticals, Inc.
13D
ADRX · 00654F105
|
9.3% |
10/5/2026
Event 9/28/2026
|
||||
| SR One Capital Management, LLC | 9.3% | |||||
| SR One Capital Fund I Aggregator, LP | 5.2% | |||||
| SR One Capital Partners I, LP | 5.2% | |||||
| SR One Capital Opportunities Fund I, LP | 1.8% | |||||
| SR One Capital Opportunities Partners I, LP | 1.8% | |||||
| SR One Co-Invest III, LLC | 1.7% | |||||
| SR One Co-Invest III Manager, LLC | 1.7% | |||||
| Amzl, LP | 0.6% | |||||
| SR One Capital SMA Partners, LP | 0.6% | |||||
| Simeon George | 9.3% | |||||
|
Zenas BioPharma, Inc.
13D/A
ZBIO · 98937L105
|
7.7% |
8/17/2026
Event 8/13/2026
|
||||
| SR One Capital Management, LLC | 7.7% | |||||
| SR One Capital Fund II Aggregator, LP | 3.0% | |||||
| SR One Capital Partners II, LP | 3.0% | |||||
| Amzl, LP | 2.9% | |||||
| SR One Capital SMA Partners, LP | 2.9% | |||||
| SR One Capital Opportunities Fund I, LP | 1.8% | |||||
| SR One Capital Opportunities Partners I, LP | 1.8% | |||||
| Simeon George | 7.7% | |||||
|
Veradermics, Inc.
13D/A
MANE · 922967104
|
4.9% |
8/14/2026
Event 8/12/2026
|
||||
| SR One Capital Management, LLC | 4.9% | |||||
| SR One Capital Fund II Aggregator, LP | 3.4% | |||||
| SR One Capital Partners II, LP | 3.4% | |||||
| Amzl, LP | 1.6% | |||||
| SR One Capital SMA Partners, LP | 1.6% | |||||
| Simeon George | 4.9% | |||||
|
Odyssey Therapeutics, Inc.
13D
ODTX · 67613T104
|
8.0% |
5/18/2026
Event 5/11/2026
|
||||
| SR One Capital Management, LLC | 8.0% | |||||
| SR One Capital Fund I Aggregator, LP | 3.9% | |||||
| SR One Capital Partners I, LP | 3.9% | |||||
| SR One Co-Invest IV, LLC | 0.8% | |||||
| SR One Co-Invest IV-A, LLC | 1.2% | |||||
| SR One Co-Invest IV Manager, LLC | 2.0% | |||||
| Amzl, LP | 2.2% | |||||
| SR One Capital SMA Partners, LP | 2.2% | |||||
| Simeon George | 8.0% | |||||
|
Avalyn Pharma Inc.
13D
AVLN · 05348Y105
|
7.5% |
5/8/2026
Event 5/1/2026
|
||||
| SR One Capital Management, LLC | 7.5% | |||||
| SR One Capital Fund II Aggregator, LP | 4.9% | |||||
| SR One Capital Partners II, LP | 4.9% | |||||
| Amzl, LP | 2.5% | |||||
| SR One Capital SMA Partners, LP | 2.5% | |||||
| Simeon George | 7.5% | |||||
|
KALA BIO, Inc.
13D/A
KALA · 483119202
|
4.6% |
10/15/2025
Event 10/14/2025
|
||||
| SR One Capital Fund II Aggregator, LP | 4.6% | |||||
| SR One Capital Partners II, LP | 4.6% | |||||
| SR One Capital Management, LLC | 4.6% | |||||
| Simeon George | 4.6% | |||||
|
ORIC Pharmaceuticals, Inc.
13D/A
ORIC · 68622P109
|
4.8% |
8/14/2025
Event 8/12/2025
|
||||
| SR One Capital Management, LLC | 4.8% | |||||
| SR One Capital Opportunities Fund I, LP | 2.5% | |||||
| SR One Capital Opportunities Partners I, LP | 2.5% | |||||
| Amzl, LP | 1.6% | |||||
| SR One Capital SMA Partners, LP | 1.6% | |||||
| SR One Capital Fund II Aggregator, LP | 0.7% | |||||
| SR One Capital Partners II, LP | 0.7% | |||||
| Simeon George | 4.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.